Cortechs.ai | Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Cortechs.ai and Hitachi announce support of Hitachi MRI scanners for NeuroQuant®

Increased Physician Access to Volumetric MRI Processing with Additional Scanner Options, Including Open MRIs

(SAN DIEGO) – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain volume analysis, is pleased to announce that Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners are compatible with NeuroQuant®, the foremost medical device software for volumetric MRI processing. Cortechs.ai and Hitachi worked together to validate the 1.2T, 1.5T and 3.0T Hitachi MRI scanners, ensuring accurate and consistent brain segmentation results for Hitachi MRI customers.

This capability provides neuroradiologists in hospitals, clinics, imaging and research centers worldwide with expanded MRI scanner options when using Cortechs.ai automated brain image analysis software solutions in the assessment of neurodegeneration disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis, as well as, brain volume changes caused by brain trauma.

Cortechs.ai’ fast, accurate, reproducible, and proven quantitative imaging solution is the first FDA cleared and CE marked software that provides radiologists and neurologists with quantifiable, volumetric data to help in the assessment of brain atrophy and lesion evolution.

“This Hitachi scanner validation marks the first time that NeuroQuant products can be used with open MRI scanners, helping to accommodate a broader patient demographic for neurodegenerative evaluations,” said Guri Stark, Cortechs.ai’ CEO. “We are excited to include Hitachi 1.2T, 1.5T and 3.0T MRI scanners as options for NeuroQuant analysis, thereby strengthening our goal of providing a vendor neutral product, allowing physicians and clinicians more freedom in MRI scanner choices.”

“We are always looking to provide our customers with enhanced and expanded imaging capabilities,” said Sheldon Schaffer, Vice President and General Manager, MR/CT, Hitachi Healthcare Americas. “With NeuroQuant products now validated and compatible with Hitachi 1.2T Oasis, 1.5T Echelon Oval and 3.0T Trillium Oval MRI scanners, healthcare providers have access to exceptional automated brain volume imaging technology, allowing them to deliver better patient care in Hitachi’s unique patient-centric environment.”

ABOUT CORTECHS LABS
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

ABOUT HITACHI HEALTHCARE AMERICAS
Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit www.hitachihealthcare.com.

ABOUT HITACHI, LTD.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at www.hitachi.com

More Resources

12/18/2025

Reimbursement Essentials for Quantitative Imaging: Key Takeaways From Our Expert Webinar

Our reimbursement webinar walked through best practices for billing, coding, and securing payment for NeuroQuant and OnQ Prostate, helping inform providers.

12/15/2025

OnQ Prostate for Radiation Oncology

OnQ Prostate is at the forefront of advanced imaging to empower the delivery of true precision therapies.

12/10/2025

Reflections on RSNA 2025 and What We Learned at the Cortechs.ai Booth 

If there was one overall takeaway from RSNA 2025, it’s that clinicians are ready for tools that reduce manual work and make reporting more consistent.

12/09/2025

Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging with Dr. Ana M. Franceschi, MD PhD.

12/09/2025

SNO 2025 Recap: Collaboration Driving Innovation in Neuro-Oncology

The 2025 Society for Neuro-Oncology meeting was more than a conference, it was a hub of collaboration and conversation among industry leaders and physicians.

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.
Scroll to Top